|
XRCC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1705000002582E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.13809999991288E-07 |
| Normal-vs-Stage2 |
2.777800E-03 |
| Normal-vs-Stage3 |
1.377490E-03 |
| Normal-vs-Stage4 |
9.602700E-04 |
| Stage1-vs-Stage2 |
4.090200E-01 |
| Stage1-vs-Stage3 |
4.132200E-01 |
| Stage1-vs-Stage4 |
6.170200E-01 |
| Stage2-vs-Stage3 |
2.321800E-01 |
| Stage2-vs-Stage4 |
2.935600E-01 |
| Stage3-vs-Stage4 |
8.355800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.31499999953289E-07 |
| Normal-vs-AfricanAmerican |
1.362100E-04 |
| Normal-vs-Asian |
9.789600E-01 |
| Caucasian-vs-AfricanAmerican |
8.394400E-02 |
| Caucasian-vs-Asian |
2.432600E-01 |
| AfricanAmerican-vs-Asian |
1.157780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81229999995924E-06 |
| Normal-vs-Female |
1.91230000001763E-06 |
| Male-vs-Female |
3.901600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.670130E-02 |
| Normal-vs-Age(41-60Yrs) |
1.97693999999249E-05 |
| Normal-vs-Age(61-80Yrs) |
3.73550000043466E-07 |
| Normal-vs-Age(81-100Yrs) |
7.265700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.821800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.252800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.511400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.148200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.695800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.084000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.739750E-02 |
| Normal-vs-Grade 2 |
2.25590000013653E-07 |
| Normal-vs-Grade 3 |
1.56062999999707E-05 |
| Normal-vs-Grade 4 |
2.690200E-02 |
| Grade 1-vs-Grade 2 |
3.777800E-01 |
| Grade 1-vs-Grade 3 |
8.847000E-01 |
| Grade 1-vs-Grade 4 |
3.989400E-01 |
| Grade 2-vs-Grade 3 |
2.533600E-01 |
| Grade 2-vs-Grade 4 |
2.720100E-02 |
| Grade 3-vs-Grade 4 |
1.850160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.63430000538401E-08 |
| Normal-vs-ccB subtype |
8.679800E-03 |
| ccA subtype-vs-ccB subtype |
6.019100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74089999996452E-06 |
| Normal-vs-N1 |
6.455800E-03 |
| N0-vs-N1 |
3.832000E-01 |
|
|
